1. Home
  2. CYCC vs IPDN Comparison

CYCC vs IPDN Comparison

Compare CYCC & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • IPDN
  • Stock Information
  • Founded
  • CYCC 1992
  • IPDN 2003
  • Country
  • CYCC United States
  • IPDN United States
  • Employees
  • CYCC N/A
  • IPDN N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • IPDN EDP Services
  • Sector
  • CYCC Health Care
  • IPDN Technology
  • Exchange
  • CYCC Nasdaq
  • IPDN Nasdaq
  • Market Cap
  • CYCC 3.6M
  • IPDN 4.3M
  • IPO Year
  • CYCC N/A
  • IPDN 2013
  • Fundamental
  • Price
  • CYCC $0.25
  • IPDN $2.37
  • Analyst Decision
  • CYCC Strong Buy
  • IPDN
  • Analyst Count
  • CYCC 1
  • IPDN 0
  • Target Price
  • CYCC $11.00
  • IPDN N/A
  • AVG Volume (30 Days)
  • CYCC 160.2K
  • IPDN 36.7K
  • Earning Date
  • CYCC 05-13-2025
  • IPDN 05-14-2025
  • Dividend Yield
  • CYCC N/A
  • IPDN N/A
  • EPS Growth
  • CYCC N/A
  • IPDN N/A
  • EPS
  • CYCC N/A
  • IPDN N/A
  • Revenue
  • CYCC $74,000.00
  • IPDN $6,730,605.00
  • Revenue This Year
  • CYCC N/A
  • IPDN N/A
  • Revenue Next Year
  • CYCC $88.68
  • IPDN N/A
  • P/E Ratio
  • CYCC N/A
  • IPDN N/A
  • Revenue Growth
  • CYCC N/A
  • IPDN N/A
  • 52 Week Low
  • CYCC $0.22
  • IPDN $1.80
  • 52 Week High
  • CYCC $4.00
  • IPDN $18.90
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 29.30
  • IPDN 40.14
  • Support Level
  • CYCC $0.29
  • IPDN $2.40
  • Resistance Level
  • CYCC $0.32
  • IPDN $2.59
  • Average True Range (ATR)
  • CYCC 0.02
  • IPDN 0.27
  • MACD
  • CYCC -0.00
  • IPDN 0.05
  • Stochastic Oscillator
  • CYCC 19.92
  • IPDN 31.76

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.

Share on Social Networks: